Furthermore, given that dietary modifications including calorie restriction and intermittent fasting decrease signaling through IR/IGF-1R, our data with BMS-754807 complement the previous literature, showing that fasting at the time of chemotherapy treatment not only reduces tumor size in mouse models but also mitigates treatment-induced side effects [54,55,56,57,58]. Here, IGF1R is linked to neoplasm.